Bausch & Lomb (NYSE:BLCO) 주식

Bausch & Lomb

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Entertainment

Asset Sales

Media

AMPS

BLCO

GRAB

NSANY

PCHM

PSFE

Sony Group Corporation American Depositary Shares

SONY

TYO:4188

블록에 등장한 신규 기업들팜켐(OTC:PCHM), 약물 감지 땀 패치의 대표 기업이 전략적 대안을 모색하고 있다(즉, 인수합병 또는 매각). 이사회는 지금까지 은행가를 고용하는 것보다 독자적으로 상황을 처리할 수 있다고 자신감을 나타냈다. 관심 있는 인수자는 공식 데이터룸에 접근할 수 있다.

딜 디스패치: 팜켐이 독자 매각을 진행, TGI 프라이데이는 $1,900만 에 19개의 레스토랑 매각

News

Markets

BTBT

FYBR

LBPH

LSPD

MSGM

NVAX

PDCO

SNDR

TCEHY

UBSFF

USAP

새로이 등장한 블록 치과용품 제조업체인 패터슨 컴퍼니즈(NASDAQ:PDCO)가 주주 가치를 높이기 위해 매각 또는 합병을 포함한 전략적 옵션을 모색 중이라고 목요일 발표했다. 이 회사는 거래 과정을 2분기 재무 보고서의 일환으로 공개했다.

딜 디스패치: 유비소프트는 매각 협상 중, 패터슨은 매각 탐색 중, 프로마의 레카로 인수 등

PRPH

WOLF

뉴 온 더 블록 아리 엠마누엘(Ari Emanuel)의 스포츠 및 엔터테인먼트 대기업인 엔데버 그룹 홀딩스(NYSE:EDR)는 마이애미 오픈 및 마드리드 오픈 테니스 토너먼트를 포함한 IMG 테니스 자산 매각 가능성을 검토하고 있다. IMG의 다른 자산 대부분은 UFC(얼티밋 파이팅 챔피언십) 및 WWE(월드 레슬링 엔터테인먼트)의 모회사인 TKO 그룹 홀딩스(NYSE:TKO)와의 목요일에 발표된 거래에 포함되었다.

딜 디스패치: UFC, WWE 모회사 TKO가 불 라이딩 인수; 엔데버가 테니스 자산 매각 검토 등

Bausch & Lomb Corp

Morgan Stanley analyst Joseph Moore maintains Marvell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) with a Equal-Weight and lowers the price target from $113 to $90.

Price Target

Analyst Ratings

MRVL

Morgan Stanley Maintains Equal-Weight on Marvell Tech, Lowers Price Target to $90

Contracts

FLUX

Flux Power Receives First Purchase Order From Medical Supply Company For Lithium-ion Battery Packs

WIIM

TRNR

Interactive Strength shares are trading higher after the company signed letter of intent and exclusivity agreement to acquire a connected-fitness equipment company.

TDOC

Teladoc Announces Pharmacy Integration Agreement With Gifthealth For  GLP-1 Self-Pay Option

MBRX

Moleculin Biotech Received Notice Of Intent To Grant For Eurpean Patent Application Titled "Method of Reconstituting Liposomal Annamycin".

Toro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTC#NYSE">TTC</a>) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.63 by 3.17 percent. This is a 1.56 percent increase over earnings of $0.64 per share from the same period last year. The company reported quarterly sales of $995.000 million which missed the analyst consensus estimate of $1.005 billion by 1.01 percent. This is a 0.70 percent decrease over sales of $1.002 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

Toro Q1 2025 Adj. EPS $0.65 Beats $0.63 Estimate, Sales $995.000M Miss $1.005B Estimate

Morgan Stanley analyst Sanjit Singh maintains MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) with a Overweight and lowers the price target from $350 to $315.

Morgan Stanley Maintains Overweight on MongoDB, Lowers Price Target to $315

NVVE

Nuvve Launches NUVVE Japan

ILAG

Intelligent Living Application Group shares are trading higher after the company announced the launch of its smart lock.

Stephens &amp; Co. analyst Jim Salera reiterates Wendy's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEN#NASDAQ">WEN</a>) with a Equal-Weight and maintains $15 price target.

Reiteration

Stephens & Co. Reiterates Equal-Weight on Wendy's, Maintains $15 Price Target

The Trump administration is exploring a strategy to halt and examine Iranian oil tankers at sea as part of an international agreement aimed at curbing the spread of <a href="https://www.benzinga.com/25/02/43480859/trump-confirms-maximum-economic-pressure-on-iran-calls-chinas-tariff-retaliation-fine">weapons of mass destruction</a>.
What Happened: According to Reuters, Trump officials are considering enabling allied nations to stop and inspect vessels passing through critical maritime routes such as Asia's Malacca Strait.
Such actions could delay crude deliveries to refiners and potentially damage the reputations of those involved in facilitating these trades.
The administration is evaluating whether these sea inspections could be conducted under the Proliferation Security Initiative (PSI), a U.S.-led program launched in 2003 with the participation of over 100 countries to prevent the movement of weapons of mass destruction. 
See Also: <a href="https://www.benzinga.com/markets/equities/25/03/44157043/jim-cramer-doubles-down-on-crowdstrike-despite-drop-analysts-who-were-so-negativehad-it-wrong">Jim Cramer Doubles Down On CrowdStrike Despite Drop: &#8216;Analysts Who Were So Negative…Had It Wrong&#8217;</a>
Why It Matters: Opponents of Tehran's oil revenue say it supports nuclear proliferation as well as terrorism.
However, past attempts to seize Iranian oil have sparked retaliation from Tehran. In 2023, Iran seized foreign ships—one chartered by Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>)—after the U.S. attempted to intercept Iranian oil cargoes.
&#8220;You don't have to sink ships or arrest people to have that chilling effect that this is just not worth the risk,&#8221; said one source, emphasizing that delivery delays could sow uncertainty in illicit trade networks. 
Analysts warn that the longer sanctions remain in place, the more Iran and its oil buyers will find ways to circumvent them.
With Iran's oil revenues largely tied to exports to China, any prolonged disruption could have significant economic impacts. 
<h2 class="wp-block-heading">ETFs To Watch</h2>
During pre-market hours on Thursday, <a href="https://pro.benzinga.com">Benzinga Pro</a> showed: 
<ul>
<li>ProShares Ultra Bloomberg Crude Oil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UCO#NYSE">UCO</a>) fell by 0.17%,</li>
<li>United States Oil Fund LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>) dropped 2.58%,</li>
<li>SPDR S&amp;P Oil &amp; Gas Exploration &amp; Production ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOP#NYSE">XOP</a>) decreased by 0.39%, and</li>
<li>MicroSectorsTM Oil &amp; Gas Exploration &amp; Production 3X Leveraged ETNs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OILU#NYSE">OILU</a>) saw a 0.28% drop,</li>
</ul>
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/forex/25/03/44161314/us-stocks-likely-to-open-lower-after-wednesdays-blip-be-patient-but-be-ready-to-act-says-analyst-as-market-uncertainties-can-create-opportunities">US Stocks Likely To Open Lower After Wednesday&#8217;s Blip: &#8216;Be Patient, But Be Ready To Act,&#8217; Says Analyst As Market Uncertainties Can Create &#8216;Opportunities&#8217;</a></li>
</ul>
Image: Shutterstock

Government

Politics

Global

OILU

Trump Administration Weighs Sea Inspections Of Iranian Oil Tankers

Macro Economic Events

Econ #s

Economics

Trade Balance For Jan -131.4B Vs -128.3B Estimate; -98.1B Prior

Keefe, Bruyette &amp; Woods analyst Ryan Tomasello maintains LendingTree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>) with a Outperform and lowers the price target from $73 to $66.

TREE

Keefe, Bruyette & Woods Maintains Outperform on LendingTree, Lowers Price Target to $66

Telsey Advisory Group analyst Dana Telsey maintains Macy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>) with a Market Perform and maintains $17 price target.

Telsey Advisory Group Maintains Market Perform on Macy's, Maintains $17 Price Target

USNonfarm Productivity (QoQ) (Q4) +1.5% vs +1.2% Est.

Macro Notification

General

US Initial Jobless Claims 221K vs 234K Est.

AGMH

AGM Group Holdings shares are trading higher after the company completed a $5.4 million public offering to expand bitcoin mining operations.

Keefe, Bruyette &amp; Woods analyst Ryan Tomasello maintains SmartRent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMRT#NYSE">SMRT</a>) with a Market Perform and lowers the price target from $2 to $1.6.

SMRT

Keefe, Bruyette & Woods Maintains Market Perform on SmartRent, Lowers Price Target to $1.6

The data were presented in a poster presentation, titled, "Autonomic, Cardiac, and Neural Effects from Non-Invasive Cervical Vagus Nerve Stimulation," at the Sixth Bioelectronic Medicine Summit, March 4 &amp; 5. The findings were based on Tivic's collaboration with The Feinstein Institute of Medicine, one of the global scientific leaders in bioelectronic medicine.

Biotech

TIVC

Tivic Health Presents Data On Nerve Stimulation Method

Keefe, Bruyette &amp; Woods analyst Sanjay Sakhrani maintains Nayax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYAX#NASDAQ">NYAX</a>) with a Market Perform and raises the price target from $33 to $38.

NYAX

Keefe, Bruyette & Woods Maintains Market Perform on Nayax, Raises Price Target to $38

Press Releases

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

Bausch + Lomb Responds to Rumors of a Potential Sale

Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual "Faces of Glaucoma" Campaign and Fundraising Challenge

Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union

Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19

Bausch + Lomb Provides Update on Potential Sale

Bausch Health Provides Update on Strategic Alternatives

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance

Comments

Bausch & Lomb

뉴스

파트너 / 기고자

벤징가 글로벌